Scrutinizing Mycobacterium tuberculosis membrane and secretory proteins to formulate multiepitope subunit vaccine against pulmonary tuberculosis by utilizing …

N Chatterjee, R Ojha, N Khatoon… - International journal of …, 2018 - Elsevier
Tuberculosis is a menacing disease caused eminently to the people inhabiting the tropical
and sub-tropical nations. A holistic approach is required to generate T and B memory cells to …

Structural and energetic understanding of novel natural inhibitors of Mycobacterium tuberculosis malate synthase

R Shukla, H Shukla, T Tripathi - Journal of Cellular …, 2019 - Wiley Online Library
Persistent infection by Mycobacterium tuberculosis requires the glyoxylate shunt. This is a
bypass to the tricarboxylic acid cycle in which isocitrate lyase (ICL) and malate synthase …

In-silico interaction studies suggest RND efflux pump mediates polymyxin resistance in Acinetobacter baumannii

P Verma, P Maurya, M Tiwari… - Journal of Biomolecular …, 2019 - Taylor & Francis
Bacterial efflux pumps have emerged as antibiotic resistance determinants and confers multi-
drug resistance to a broad range of antimicrobials as well as non-antibiotic substances. A …

Identification of novel natural inhibitors of Opisthorchis felineus cytochrome P450 using structure-based screening and molecular dynamic simulation

R Shukla, PB Chetri, A Sonkar… - Journal of …, 2018 - Taylor & Francis
Opisthorchis felineus is the etiological agent of opisthorchiasis in humans. O. felineus
cytochrome P450 (OfCYP450) is an important enzyme in the parasite xenobiotic …

Developing a multi-epitope vaccine candidate to combat porcine epidemic diarrhea virus and porcine deltacoronavirus co-infection by employing an …

W Hou, H Wu, W Wang, R Wang, W Han… - Frontiers in …, 2023 - frontiersin.org
Coinfection of porcine epidemic diarrhea virus (PEDV) and porcine deltacoronavirus
(PDCoV) is common in pig farms, but there is currently no effective vaccine to prevent this co …

Activity loss by H46A mutation in Mycobacterium tuberculosis isocitrate lyase is due to decrease in structural plasticity and collective motions of the active site

R Shukla, H Shukla, T Tripathi - Tuberculosis, 2018 - Elsevier
Mycobacterium tuberculosis isocitrate lyase (MtbICL) is a crucial enzyme of the glyoxylate
cycle and is a validated anti-tuberculosis drug target. Structurally distant, non-active site …

Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis

MF Khan, A Ali, HM Rehman, S Noor Khan… - Scientific Reports, 2024 - nature.com
Tuberculosis (TB), caused by Mycobacterium tuberculosis, ranks among the top causes of
global human mortality, as reported by the World Health Organization's 2022 TB report. The …

Exploratory algorithm to devise multi-epitope subunit vaccine by investigating Leishmania donovani membrane proteins

N Khatoon, RK Pandey, R Ojha… - Journal of …, 2019 - Taylor & Francis
Visceral leishmaniasis (VL) is a deadly parasitic infection which affects poorest to poor
population living in the endemic countries. Increasing resistant to existing drugs, disease …

Applications of Ensemble Docking in Potential Inhibitor Screening for Mycobacterium tuberculosis Isocitrate Lyase Using a Local Plant Database

YV Lee, SB Choi, HA Wahab, TS Lim… - Journal of chemical …, 2019 - ACS Publications
Isocitrate lyase (ICL) is a persistent factor for the survival of dormant stage Mycobacterium
tuberculosis (MTB), thus a potential drug target for tuberculosis treatment. In this work …

Structure-based discovery of phenyl-diketo acids derivatives as Mycobacterium tuberculosis malate synthase inhibitors

R Shukla, H Shukla, T Tripathi - Journal of Biomolecular Structure …, 2021 - Taylor & Francis
Mycobacterium tuberculosis remains one of the most successful bacterial pathogens
worldwide. The development of drug-resistant strains and the ability of the bacteria to persist …